Cancer Health Treatment Update News From the ASCO Annual Meeting The American Society of Clinical Oncology conference went virtual again this year, but there was still plenty of practice-changing news. Lynparza Follow-Up Treatment Delays Breast Cancer Recurrence PARP inhibitor reduces the risk of disease recurrence in BRCA-positive people with high-risk early breast cancer. Outreach Program Doubles the Percentage of Black Participants in Clinical Trials A five-year effort by Penn’s Abramson Cancer Center increased clinical trial enrollment of Black patients with cancer from 12% to 24%. Advertisement Immunotherapy Delays Recurrence In Kidney Cancer Patients In patients at high risk of relapse, adjuvant therapy with Keytruda prolonged disease-free survival. Nasal Swab Test Could Lead to Fewer Biopsies to Detect Lung Cancer A new nasal swab test may help identify which people with lung nodules are at most risk for lung cancer and require a biopsy. News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Spring 2021 Check out our latest print edition! Newsfeed Outreach Program Doubles the Percentage of Black Participants in Clinical Trials Nasal Swab Test Could Lead to Fewer Biopsies to Detect Lung Cancer Southern Health Centers Unite for $9.8M to Study Latino Cancer Survivorship Is Cancer a Mostly Modern Phenomenon? Maybe Not. Blog: Food and Drug Administration (FDA) FDA Approves Truseltiq for Metastatic Cholangiocarcinoma FDA Approves Opdivo for Resected Esophageal Cancer FDA Approves Keytruda for HER2-Positive Stomach Cancer FDA Authorizes First Device that Uses Artificial Intelligence to Help Detect Colon Cancer Newsfeed Outreach Program Doubles the Percentage of Black Participants in Clinical Trials Nasal Swab Test Could Lead to Fewer Biopsies to Detect Lung Cancer Southern Health Centers Unite for $9.8M to Study Latino Cancer Survivorship Is Cancer a Mostly Modern Phenomenon? Maybe Not. Blog: Food and Drug Administration (FDA) FDA Approves Truseltiq for Metastatic Cholangiocarcinoma FDA Approves Opdivo for Resected Esophageal Cancer FDA Approves Keytruda for HER2-Positive Stomach Cancer FDA Authorizes First Device that Uses Artificial Intelligence to Help Detect Colon Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: